Company intelligence / Profile preview

Rigicon

Ronkonkoma, New York, United Statesrigicon.com ↗

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

Rigicon has achieved significant clinical milestones with its urological implants. The ContiReflex artificial urinary sphincter demonstrated a 98% device survival rate at 18 months and minimal complications in early studies of 50 patients. The Testi10 testicular prosthesis showed a 99.8% survival rate over 54 months among 427 patients, with very low revision rates and no major complications reported. These results highlight strong safety and reliability profiles for their products.

Therapeutic areas: Men's Health
Modalities: Device (specifically, implantable medical devices for urology)
Industry: Implantable Medical Devices

Drug pipeline

2 assets

Rigi10

Commercial

Indications: Erectile dysfunction

1 more asset in the full pipeline.

Request access →

Partnerships

none publicly disclosed; operates independently but participates alongside major players like Boston Scientific and Coloplast within the erectile dysfunction device market

Beyond the preview

Go deeper on Rigicon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rigicon.

Explore the full profile